UNIMED and Vieco partner to enhance access to affordable, quality medications in the UAE
UNIMED, a leading healthcare solutions provider in the UAE, has signed a strategic distribution agreement with Vieco at Arab Health 2025. This partnership will enhance patient access to high-quality, cost-effective generic medications, supporting UNIMED's mission to improve healthcare outcomes across the UAE.
Under the agreement, UNIMED will distribute Vieco's reliable and affordable generic formulations, ensuring that healthcare providers and patients in the UAE have access to essential treatments at competitive prices. "This partnership with Vieco reflects our commitment to expanding access to high-quality, locally manufactured medications that meet the needs of patients and healthcare providers in the UAE," said Ahmad Jarrar, general manager of UNIMED. "By supporting local pharmaceutical production, we contribute to a more sustainable and self-reliant healthcare sector while maintaining the highest standards of quality and affordability."
"Our collaboration with UNIMED marks a significant step in our mission to provide effective and accessible medicines across the UAE," said Dr Hani El Maydaa, general manager of Vieco Pharmaceuticals. "Together, we are ensuring that patients receive the high-quality treatments they need while strengthening the local pharmaceutical industry."
The agreement was signed during Arab Health 2025, further strengthening UNIMED's role in expanding access to essential medications in the UAE.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hi Dubai
21-04-2025
- Hi Dubai
UAE Healthcare Breaks Ground with Historic Surgeries and Future-Ready Innovations in 2025
The UAE's healthcare sector is cementing its global leadership in 2025 through a string of landmark procedures and groundbreaking innovations across critical specialties. From historic surgeries to futuristic tech, the nation's medical institutions are redefining excellence. Kings College Hospital London Dubai recently performed the city's first liver transplant on a 13-month-old child, born with biliary atresia and a congenital heart defect. The complex case, supported by Al Jalila Foundation, highlights the depth of pediatric expertise now available locally. Cleveland Clinic Abu Dhabi made global headlines with the world's first remotely performed robotic-assisted focal therapy for prostate cancer. Using the Focal-One system, the procedure eliminated the need for invasive surgery. The hospital also carried out the UAE's first simultaneous robotic kidney transplant for donor and recipient using a single robot. Women's health saw a leap forward at Corniche Hospital with a minimally invasive egg collection and freezing procedure, offering a new frontier in fertility care. In regenerative medicine, the Abu Dhabi Stem Cells Centre reported promising results for Type 1 diabetes treatment using umbilical cord-derived stem cells. Major strides were also revealed at Arab Health 2025, where Emirates Health Services introduced two ambitious projects: artificial heart transplantation and pancreatic cell transplantation. Meanwhile, a clinical trial in Abu Dhabi on StromaForte for knee osteoarthritis showed strong potential in cell-based therapy. Looking ahead, M42 will bring heavy ion therapy—among the most advanced cancer treatments—to Cleveland Clinic Abu Dhabi. The hospital also launched a BioButton-powered remote monitoring programme for cancer patients during Abu Dhabi Global Healthcare Week, underscoring the UAE's commitment to personalized, tech-driven care. With AI, robotics, and precision medicine at the forefront, the UAE continues to reshape the future of global healthcare. News Source: Emirates News Agency
Gulf Today
19-04-2025
- Gulf Today
UAE healthcare sector sees massive advancement
The UAE's healthcare sector has reinforced its leading position since the beginning of the year through a series of rare surgical procedures and the adoption of innovative treatments for critical illnesses, underscoring the high calibre of medical expertise across various specialties. The UAE has transformed its healthcare system into a globally advanced model by investing in cutting-edge technologies such as artificial intelligence, therapeutic robots, and 3D printing to enhance the quality and sustainability of care. Kings College Hospital London Dubai announced on Thursday the city's first liver transplant on a 13-month-old child, with the support of Al Jalila Foundation – the philanthropic arm of Dubai Health. The child was born with a rare condition known as biliary atresia, which caused his health to deteriorate despite an earlier surgical procedure to connect his liver to his intestines. He was also diagnosed with a congenital heart defect (atrial septal defect). He was referred to King's College Hospital in Dubai by Al Jalila Children's Hospital, following the cardiac repair procedure. Cleveland Clinic Abu Dhabi performed the world's first remotely conducted transcontinental robotic-assisted focal therapy for prostate cancer. Focal therapy is a non-invasive treatment that precisely targets a specific section of the prostate using ultrasound beams, eliminating the need for major surgery or radiation. The Focal-One system enhances this approach with a robotic arm that ensures precise and controlled ultrasound delivery. In January, Cleveland Clinic Abu Dhabi also announced the UAE's first simultaneous robotic kidney transplant procedure for a donor and recipient using one robot. Corniche Hospital has successfully performed a minimally invasive laparoscopic procedure for egg collection and freezing, a cutting-edge technique representing a significant leap forward in reproductive medicine. The UAE's medical sector has also seen significant progress in implementing new and innovative treatments this year. In January, the Abu Dhabi Stem Cells Centre reported promising results in treating Type 1 diabetes using umbilical cord-derived mesenchymal stem cell (UC-MSC) therapy. The Emirates Health Services (EHS) unveiled two innovative projects – an 'Artificial Heart Transplantation' and 'Pancreatic Cell Transplantation' at Arab Health 2025 in January. In April, the Department of Health – Abu Dhabi completed a groundbreaking clinical trial in Abu Dhabi. WAM
Al Etihad
18-04-2025
- Al Etihad
UAE healthcare sector advances in 2025 with rare surgeries, innovative treatments
18 Apr 2025 14:13 ABU DHABI (WAM)The UAE's healthcare sector has reinforced its leading position since the beginning of the year through a series of rare surgical procedures and the adoption of innovative treatments for critical illnesses, underscoring the high calibre of medical expertise across various UAE has transformed its healthcare system into a globally advanced model by investing in cutting-edge technologies such as artificial intelligence, therapeutic robots, and 3D printing to enhance the quality and sustainability of College Hospital London Dubai announced on Thursday the city's first liver transplant on an infant, a 13-month-old child, with the support of Al Jalila Foundation – the philanthropic arm of Dubai Health. The child was born with a rare condition known as biliary atresia, which caused his health to deteriorate despite an earlier surgical procedure to connect his liver to his intestines. He was also diagnosed with a congenital heart defect (atrial septal defect). The child was referred to King's College Hospital in Dubai by Al Jalila Children's Hospital, following the cardiac repair Clinic Abu Dhabi performed the world's first remotely conducted transcontinental robotic-assisted focal therapy for prostate cancer. Focal therapy is a non-invasive treatment that precisely targets a specific section of the prostate using ultrasound beams, eliminating the need for major surgery or radiation. The Focal-One system enhances this approach with a robotic arm that ensures precise and controlled ultrasound January, Cleveland Clinic Abu Dhabi also announced the UAE's first simultaneous robotic kidney transplant procedure for a donor and recipient using one Hospital has successfully performed a minimally invasive laparoscopic procedure for egg collection and freezing, a cutting-edge technique representing a significant leap forward in reproductive UAE's medical sector has also seen significant progress in implementing new and innovative treatments this year. In January, the Abu Dhabi Stem Cells Centre reported promising results in treating Type 1 diabetes using umbilical cord-derived mesenchymal stem cell (UC-MSC) Emirates Health Services (EHS) unveiled two innovative projects – an Artificial Heart Transplantation and an Pancreatic Cell Transplantation at Arab Health 2025 in April, the Department of Health – Abu Dhabi also completed a groundbreaking clinical trial in Abu Dhabi. The treatment, StromaForte, has shown a favourable safety profile and significant therapeutic potential for knee osteoarthritis, marking a significant step in evaluating cell-based therapies for degenerative joint diseases.M42, a leading global health technology company powered by AI, is meanwhile set to build a heavy ion therapy facility at Cleveland Clinic Abu Dhabi, bringing one of the most advanced and effective cancer treatment technologies to the Middle East. During Abu Dhabi Global Healthcare Week 2025, which concluded on Thursday, Cleveland Clinic Abu Dhabi also unveiled initiatives and new technologies to improve cancer patient care, including an innovative remote monitoring programme, using the BioButton wearable device, for cancer patients at the Fatima Bint Mubarak Centre.
